VCBeat Explores Innovation in Pharmaceutical Distribution and Retail: Grassroots Expansion, M&A Integration, Prescription Diversion, and New Retail

For the pharmaceutical distribution and retail industry, this is an era of rapid change, driven by factors such as policy shifts, capital flows, technological advancements, industrial upgrade demands, and consumer-driven trends.

We have questions: How should pharmaceutical distributors respond to the “Two-Invoice System” and the VAT reform? How can individual agents transition into professional Contract Sales Organizations (CSOs)? How will third-party pharmaceutical logistics companies capture a share of the pharmaceutical distribution market? How should mergers, acquisitions, and industry consolidation be carried out? And how should the upstream and downstream segments of the industry chain develop?

How can pharmaceutical retail enterprises accommodate the trend of "prescription outflow," transition from selling products to providing services, integrate various digital tools to streamline marketing and customer management, and ultimately realize the "new retail" model in the pharmaceutical industry?

Fortunately, we have seen outstanding pioneers...

To strengthen the supply of primary healthcare services, restrictions on medication prescribing at the primary care level have been lifted, leading to rapid growth in the primary pharmaceutical market. Consequently, pharmaceutical distribution companies are placing greater emphasis on this sector. Amidst the comprehensive rise of the primary healthcare market, major pharmaceutical commercial enterprises—represented by Sinopharm Group, Shanghai Pharmaceuticals, and China Resources Pharmaceutical—are increasingly prioritizing the primary care segment. They are boosting their investments in this area through academic promotion, physician education, network development, and patient education initiatives.

From Challenger to Collaborator: SF Express’s pharmaceutical logistics network now covers 132 prefecture-level cities, with three pharmaceutical cold storage warehouses and 12 dedicated pharmaceutical trunk lines. Beyond SF Express, companies such as China Post, JD.com, and DHL have also entered the pharmaceutical logistics sector to varying degrees, turning this market into a new “battleground” for logistics providers.

Professional investment institutions such as Tianyi Capital, GF Xinde, and Hillhouse Capital, along with industrial enterprises including GPC Baiyunshan, Tasly Group, and Buchang Pharmaceuticals, have actively participated in investments and mergers and acquisitions within the pharmaceutical retail sector. Coupled with listed pharmaceutical retail companies intensifying their acquisition of small pharmacy chains, the “land grab” campaign in the pharmaceutical retail industry is unfolding with great momentum.

Thanks to the continued advancement of the “separation of prescribing and dispensing” policy, prescription outflow is on the verge of a full-scale surge. Currently, there are five primary models for handling prescription outflow: hospital-adjacent pharmacies, entrusted pharmacy services, Direct-to-Patient (DTP) pharmacies, prescription sharing platforms, and online consultation with home delivery.

Each of these models has representative cases, such as Shanghai Pharmaceuticals’ managed pharmacy, DTP pharmacy, and e-prescription models; National Drugstore’s aggressive expansion into the “hospital-adjacent store + DTP pharmacy” model; other innovative models include Alibaba Health’s online consultation and delivery model, and WeChat’s “Smart Pharmacy” model.

From June 9 to 10, 2018, VCBeat will host the “2018 Summit on Innovative Practices in Primary Healthcare” in Hangzhou, Zhejiang. Hot topics in the pharmaceutical distribution and retail industry will be a key focus of our discussions.

We have invited distinguished guests, including Ji Jun, General Manager of Shanghai Pharma Cloud Health; Wang Letian, General Manager of Sinopharm Online; Wang Lijue, Founder of Akang Health; Dian Canghe, Founder of Medicine Cloud Studio; Zhang Xiaodong, Founder of Medbanks Health; and Wang Hao, General Manager of Xingbang Health, to discuss the key trends they observe in the pharmaceutical distribution and retail sector and to share their strategies for navigating change.

VCBeat has been striving to establish a professional and rigorous content production system, aiming to empower its authors to become experts in their respective fields and consistently deliver forward-looking, in-depth insights to the industry. If our content can provide tangible assistance to practitioners or stimulate reflection on their business practices, it would represent the greatest affirmation of our media value.

We hope to use our pens to document this era of rapid change and immense challenge. As engaging with industry guests is our sole avenue for acquiring knowledge and understanding the sector, we deeply cherish every opportunity for face-to-face interaction with the industry.

June 9–10, Hangzhou, Zhejiang: VCBeat hosts the “2018 Summit on Innovative Practices in Primary Healthcare.” We look forward to your participation and meaningful discussions.

Long-press or scan the QR code above to access the registration portal.

Scan the QR code to join the group and receive your report!